Skip to main content
Veterinary Medicines

PRIMUN BLUETONGUE S1-8 ONE SHOT

Authorised
  • Bluetongue virus, serotype 1, strain ALG2006/01 E1, Inactivated
  • Bluetongue virus, Serotype 8, strain BTV-8/BEL2006/02, Inactivated

Product identification

Medicine name:
PRIMUN BLUETONGUE S1-8 ONE SHOT
Active substance:
  • Bluetongue virus, serotype 1, strain ALG2006/01 E1, Inactivated
  • Bluetongue virus, Serotype 8, strain BTV-8/BEL2006/02, Inactivated
Target species:
  • Sheep
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Bluetongue virus, serotype 1, strain ALG2006/01 E1, Inactivated
    1.28
    log10 serum neutralising unit(s)
    /
    1.00
    Dose
  • Bluetongue virus, Serotype 8, strain BTV-8/BEL2006/02, Inactivated
    1.40
    log10 serum neutralising unit(s)
    /
    1.00
    Dose
Pharmaceutical form:
  • Suspension for injection
Withdrawal period by route of administration:
  • Subcutaneous use
    • Sheep
      • All relevant tissues
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI04AA02
Authorisation status:
  • Valid
Authorised in:
  • France
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Laboratorios Calier S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Laboratorios Calier S.A.
Responsible authority:
  • National Veterinary Medicines Agency
Authorisation number:
  • FR/V/1571453 2/2010
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 7/04/2022
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."